|
1-20 (of 458 results)
| Most recent content
(19 Jun 2008):
|
Focus on Research: Cancer Immunotherapy The Endgame Begins
Weiner L. M.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2664-2665, Jun 19, 2008.
Perspective
Brief Report:Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
Hunder N. N., Wallen H., Cao J., Hendricks D. W., Reilly J. Z., Rodmyre R., Jungbluth A., Gnjatic S., Thompson J. A., Yee C.
Summary |
Full Text |
PDF
N Engl J Med 2008;
358:2698-2703, Jun 19, 2008.
Original Articles
Molecular Origins of Cancer: Cancer Immunology
Finn O. J.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2704-2715, Jun 19, 2008.
Review Articles
| Earlier content
(since Jan 1996):
|
Graves' Disease
Brent G. A.
Extract |
Full Text |
PDF |
CME Exam
N Engl J Med 2008;
358:2594-2605, Jun 12, 2008.
Clinical Practice
Case 18-2008 A 68-Year-Old Man with Headache and Visual Changes after Liver Transplantation
Seton M., Pless M., Fishman J. A., Caruso P. A., Hedley-Whyte E. T.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2619-2628, Jun 12, 2008.
Case Records of the Massachusetts General Hospital
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Kishimoto T. K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J. C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G. S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Dal Pan G. J., Shriver Z., Langer R. S., Venkataraman G., Austen K. F., Woodcock J., Sasisekharan R.
Abstract |
Full Text |
PDF
N Engl J Med 2008;
358:2457-2467, Jun 5, 2008;
published at www.nejm.org on Apr 23, 2008 (10.1056/NEJMoa0803200).
Original Articles
Heparin Comes Clean
Schwartz L. B.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2505-2509, Jun 5, 2008.
Editorials
Sublingual Immunotherapy
Frew A. J.
Extract |
Full Text |
PDF |
CME Exam
N Engl J Med 2008;
358:2259-2264, May 22, 2008.
Clinical Therapeutics
How HIV Guts the Immune System
Johnson R. P.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2287-2289, May 22, 2008.
Clinical Implications of Basic Research
Brief Report:An Immunodeficiency Disease with RAG Mutations and Granulomas
Schuetz C., Huck K., Gudowius S., Megahed M., Feyen O., Hubner B., Schneider D. T., Manfras B., Pannicke U., Willemze R., Knüchel R., Göbel U., Schulz A., Borkhardt A., Friedrich W., Schwarz K., Niehues T.
Summary |
Full Text |
PDF
N Engl J Med 2008;
358:2030-2038, May 8, 2008.
Original Articles
Case 13-2008 A 46-Year-Old Man with Rheumatoid Arthritis and Lymphadenopathy
Munshi N. C., Digumarthy S., Rahemtullah A.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:1838-1848, Apr 24, 2008.
Case Records of the Massachusetts General Hospital
Case 11-2008 A 45-Year-Old Man with Changes in Mental Status after Liver Transplantation
Fishman J. A., Gonzalez R. G., Branda J. A.
Extract |
Full Text |
PDF |
CME Exam
N Engl J Med 2008;
358:1604-1613, Apr 10, 2008.
Case Records of the Massachusetts General Hospital
Mechanisms of Disease: Atopic Dermatitis
Bieber T.
Extract |
Full Text |
PDF |
CME Exam
N Engl J Med 2008;
358:1483-1494, Apr 3, 2008.
Review Articles
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
Rothenberg M. E., Klion A. D., Roufosse F. E., Kahn J. E., Weller P. F., Simon H.-U., Schwartz L. B., Rosenwasser L. J., Ring J., Griffin E. F., Haig A. E., Frewer P. I.H., Parkin J. M., Gleich G. J., the Mepolizumab HES Study Group
Abstract |
Full Text |
PDF
N Engl J Med 2008;
358:1215-1228, Mar 20, 2008;
published at www.nejm.org on Mar 16, 2008 (10.1056/NEJMoa070812).
Original Articles
Combating the Eosinophil with AntiInterleukin-5 Therapy
Wechsler M. E.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:1293-1294, Mar 20, 2008;
published at www.nejm.org on Mar 16, 2008 (10.1056/NEJMe0800524).
Editorials
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
Rothenberg M. E., Klion A. D., Roufosse F. E., Kahn J. E., Weller P. F., Simon H.-U., Schwartz L. B., Rosenwasser L. J., Ring J., Griffin E. F., Haig A. E., Frewer P. I.H., Parkin J. M., Gleich G. J., the Mepolizumab HES Study Group
Abstract |
Full Text |
PDF
N Engl J Med 2008;
published at www.nejm.org on
Mar 16, 2008
(10.1056/NEJMoa070812).
Original Articles
Combating the Eosinophil with AntiInterleukin-5 Therapy
Wechsler M. E.
Extract |
Full Text |
PDF
N Engl J Med 2008;
published at www.nejm.org on
Mar 16, 2008
(10.1056/NEJMe0800524).
Editorials
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose- -1,3-Galactose
Chung C. H., Mirakhur B., Chan E., Le Q.-T., Berlin J., Morse M., Murphy B. A., Satinover S. M., Hosen J., Mauro D., Slebos R. J., Zhou Q., Gold D., Hatley T., Hicklin D. J., Platts-Mills T. A.E.
Abstract |
Full Text |
PDF
N Engl J Med 2008;
358:1109-1117, Mar 13, 2008.
Original Articles
Brief Report:VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina V., Jefferson J. A., Kowalewska J., Hochster H., Haas M., Weisstuch J., Richardson C., Kopp J. B., Kabir M. G., Backx P. H., Gerber H.-P., Ferrara N., Barisoni L., Alpers C. E., Quaggin S. E.
Summary |
Full Text |
PDF
N Engl J Med 2008;
358:1129-1136, Mar 13, 2008.
Original Articles
Drug Therapy: EGFR Antagonists in Cancer Treatment
Ciardiello F., Tortora G.
Extract |
Full Text |
PDF |
CME Exam
N Engl J Med 2008;
358:1160-1174, Mar 13, 2008.
Review Articles
|